TNYA Tenaya Therapeutics Inc
Price (delayed)
$0.4988
Market cap
$43.69M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.31
Enterprise value
$52.97M
Highlights
The EPS has increased by 22% year-on-year and by 9% since the previous quarter
The net income is up by 10% year-on-year and by 5% since the previous quarter
The debt has grown by 10% year-on-year but it has declined by 6% since the previous quarter
TNYA's equity is down by 33% YoY and by 18% from the previous quarter
The quick ratio is down by 22% QoQ and by 16% YoY
Key stats
What are the main financial stats of TNYA
Market
Valuations
Earnings
Shares outstanding
87.58M
Market cap
$43.69M
Enterprise value
$52.97M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.43
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$115.95M
Net income
-$111.13M
EBIT
-$111.13M
EBITDA
-$99.27M
Free cash flow
-$91.53M
Per share
Balance sheet
Liquidity
EPS
-$1.31
EPS diluted
-$1.31
Free cash flow per share
-$1.08
Book value per share
$1.17
Revenue per share
$0
TBVPS
$1.41
Total assets
$119.94M
Total liabilities
$27.09M
Debt
$13.61M
Equity
$92.85M
Working capital
$51.4M
Debt to equity
0.15
Current ratio
4.22
Quick ratio
3.85
Net debt/EBITDA
-0.09
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-73%
Return on equity
-89.3%
Return on invested capital
-95.5%
Return on capital employed
-106.9%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
TNYA stock price
How has the Tenaya Therapeutics stock price performed over time
Intraday
-4.08%
1 week
-22.35%
1 month
13.36%
1 year
-89.11%
YTD
-65.12%
QTD
-12.51%
Financial performance
How have Tenaya Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$115.95M
Net income
-$111.13M
Gross margin
N/A
Net margin
N/A
The operating income has grown by 12% year-on-year and by 6% since the previous quarter
The net income is up by 10% year-on-year and by 5% since the previous quarter
Growth
What is Tenaya Therapeutics's growth rate over time
Valuation
What is Tenaya Therapeutics stock price valuation
P/E
N/A
P/B
0.43
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has increased by 22% year-on-year and by 9% since the previous quarter
TNYA's P/B is 75% below its last 4 quarters average of 1.7
TNYA's equity is down by 33% YoY and by 18% from the previous quarter
Efficiency
How efficient is Tenaya Therapeutics business performance
Tenaya Therapeutics's return on equity has decreased by 28% YoY and by 3.6% QoQ
The ROA has contracted by 22% YoY and by 2.7% from the previous quarter
TNYA's ROIC is up by 4.9% QoQ
Dividends
What is TNYA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for TNYA.
Financial health
How did Tenaya Therapeutics financials performed over time
Tenaya Therapeutics's total assets has decreased by 30% YoY and by 15% from the previous quarter
The quick ratio is down by 22% QoQ and by 16% YoY
The debt is 85% smaller than the equity
TNYA's debt to equity has surged by 67% year-on-year and by 15% since the previous quarter
TNYA's equity is down by 33% YoY and by 18% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.